康恩贝: 关于2022年股票期权激励计划首次授予股票期权第一个行权期限制行权期间调整的提示性公告

Core Viewpoint - The announcement details the adjustment of the exercise period for the stock options granted under the 2022 stock option incentive plan of Zhejiang Kang En Bei Pharmaceutical Co., Ltd. due to changes in the company's 2024 profit distribution plan [1][2]. Group 1 - The original exercise period was set from May 29, 2025, to June 19, 2025, during which all incentive recipients were restricted from exercising their options [2]. - The adjusted exercise period is now from May 29, 2025, to June 25, 2025, maintaining the restriction on all incentive recipients during this time [2]. - The announcement is made in compliance with the relevant regulations from the China Securities Regulatory Commission and the company's own stock option incentive plan [1].